Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well that's very interesting! Nice link, haven't heard that.
Chinese Microarray Market....
Arrayit is a player..
https://menafn.com/1099857682/China-DNA-Microarray-Market-Report-2019
Not many people know about the company yet cj, but we should start to see nice gains as more and more find it, plus waiting on huge updates from the company of course:)
It's always good to keep in mind the larger picture.
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, fulfilled an FDA clinical instrumentation contract, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing and electronic Medicare reimbursement from the Centers for Medicare and Medicaid Services, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations, announced an allergy testing services agreement with a major health and wellness provider, provided a letter to shareholders from the company's Chief Executive Officer, received endorsement by First Pediatrics Medical Group, announced in-network allergy testing services contracting with a top five commercial health benefits company, doubled its weekly billing guidance to $2 million per week, appointed an Apple enterprise healthcare partner to accelerate revenues and earnings growth, expanded allergy testing services evaluation with a major retail pharmacy chain, grew its allergy testing healthcare network to more than 700 clinics, retained a top credentialing company to accelerate commercial and government payor reimbursement, aced five consecutive rounds of proficiency testing with a top proficiency testing leader, signed an in-network allergy testing services agreement with a major California-based health benefits company, received a certificate of deemed status into 2020 from the California Department of Public Health and expanded its clinic network in Hawaii. Philippines test revenues and earnings will be reported in the company's upcoming audited quarterly and annual financial statements.
CEO Rene Schena states, "Global expansion of our health and wellness testing services in the Philippines is in keeping with our mission to make healthcare more accessible internationally. With universal healthcare coverage and a rising standard of living, the Philippines offers a tremendous growth opportunity for Arrayit and its shareholders as we expand into Southeast Asia and points beyond."
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the biotechnology, pharmaceutical, clinical and healthcare sectors through the discovery, development and manufacture of proprietary life science and personalized medicine products and services to advance biomedical research and improve human health and wellness. Please visit www.arrayit.com for more information.
https://www.marketwatch.com/press-release/arrayit-corporation-announces-global-expansion-of-finger-stick-health-and-wellness-testing-services-2019-07-29-61841734?siteid=bigcharts&dist=bigcharts
The term Arrayit Blood Cards was used in this ongoing clinical trial. It appears that they are using the blood cards daily if one views the day to day activity on the link provided down below. IMO this means they are probably utilizing the instrumentation & software, which was purchased mid 2018 in order to run daily tests at their facility... Massive FDA contracts & this breakthrough technology would facilitate clinical trials going forward...
https://www.clinicaltrials.gov/ct2/show/record/NCT04095052?view=record
Arrayit Corporation Fulfills Clinical Instrumentation Contract with the United States Food and Drug Administration
https://finance.yahoo.com/news/arrayit-corporation-fulfills-clinical-instrumentation-103000472.html
https://www.fpds.gov/ezsearch/fpdsportal?q=arrayit&s=FPDSNG.COM&templateN=&&templateName=1.5.1&indexName=awardfull
a. FDA DUNS# 962379470
https://www.usaspending.gov/#/award/67069919
https://www.accessdata.fda.gov/scripts/sda/sdDetailNavigation.cfm?sd=srolist&id=8774BCAC40B16AD6E053564DA8C0CD02&rownum=1
https://www.fpds.gov/ezsearch/fpdsportal?q=arrayit&s=FPDSNG.COM&templateN=&&templateName=1.5.1&indexName=awardfull
http://arrayit.com/Arrayit_Corporation_ARYC_Corpo/Microarray_Media__Press/Arrayit_Corporation_Ships_Clin/arrayit_corporation_ships_clinical_instrumentation_and_software_.html
https://clinicaltrials.gov/ct2/show/NCT03514303
Arrayit is also on the SRO list:
https://www.fda.gov/media/107400/download
Definition and impact of SRO listed companies:
https://www.investopedia.com/terms/s/sro.asp
b. Arrayit reports $155,000 microarray platform RFQ from the United States Food and Drug Administration FDA
c. 1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance https://www.fda.gov
d. 3-14-18: Arrayit clinical team submits requested standard operating procedures SOPs and other documentation required for submission of a major microarray technology product to the United States Food and Drug Administration FDA for FDA regulatory clearance https://www.fda.gov
e. 4-30-18: Arrayit government contracts team quotes $76,500 microarray life sciences instrument sale to a top official at the United States Food and Drug Administration FDA headquartered in Silver Spring Maryland and ensuring the safety of the nation's food and drugs https://www.fda.gov
f. 5-17-18: Arrayit clinical team confirms meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major product line. The FDA is headquartered in Silver Spring Maryland USA and improves healthcare by ensuring public safety https://www.fda.gov
g. 6-19-18: Arrayit CLIA clinical team confirms July 2 2018 meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major microarray product line. The FDA is HQ in Maryland USA and funded by a massive $4.9 billion annual budget https://www.fda.gov
h. 6-27-18: Arrayit CLIA clinical team schedules 7/1 Sunday evening dinner meeting in advance of the 7/2 meeting with top officials at the United States Food and Drug Administration FDA HQ in Silver Spring Maryland USA and regulating $1 trillion+ in consumer products https://www.fda.gov
i. 7-2-18: Arrayit CLIA clinical team meets with top brass at the United States Food and Drug Administration FDA to discuss FDA approval of a major product line. The FDA is headquartered in Silver Spring Maryland USA and oversees $1 trillion+ in consumer products https://www.fda.gov
j. 7-3-18: Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.
k. 7-16-18: July 16, 2018 - Sunnyvale, CA - Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, announces the sale of clinical instrumentation to the United States Food and Drug Administration (FDA). Arrayit uses the same clinical instrumentation in its Clinical Laboratory Improvement Amendments (CLIA) laboratory licensed by the Centers for Medicare and Medicaid Services (CMS) and the State of California Department of Public Health (CDPH). The instrumentation reads and reports test results for the company's allergy and dietary wellness tests and pipeline tests for ovarian cancer and Parkinson's Disease (PD). https://www.marketwatch.com/press-release/arrayit-corporation-reports-clinical-instrumentation-sale-to-the-united-states-food-and-drug-administration-2018-07-16?siteid=bigcharts&dist=bigcharts
Award ID (Mod#):
75F40118P10123 ( 0 ) (View) Award Type: PURCHASE ORDER
Vendor Name: ARRAYIT CORPORATION Contracting Agency: FOOD AND DRUG ADMINISTRATION
Date Signed: July 09, 2018 Action Obligation: $43,380
Referenced IDV: Contracting Office: FDA OFFICE OF ACQ GRANT SVCS
NAICS (Code): ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING ( 334516 ) PSC (Code): LABORATORY EQUIPMENT AND SUPPLIES ( 6640 )
Vendor City: SUNNYVALE Vendor DUNS: 962379470
Vendor State: CA Vendor ZIP: 940854518
Global Vendor Name: ARRAYIT CORPORATION Global DUNS Number: 962379470
https://www.usaspending.gov/#/award/67069919
l. 9-24-18: Arrayit new GlobeNewswire press release "Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration" is important because it empowers top FDA scientists with the same technology we use in our CLIA lab https://finance.yahoo.com/news/arrayit-corporation-ships-clinical-instrumentation-093000351.html …
m. 12-20-18: Arrayit web team adds most recent 12/17/2018 GlobeNewswire press "Arrayit Corporation Fulfills Clinical Instrumentation Contract with the United States Food and Drug Administration" to the home, corporate and investor pages for shareholder convenience http://arrayit.com/index.html
n. 2-21-19: Arrayit accounting department reports $43,000 clinical instrumentation payment from the top United States Food and Drug Administration FDA HQ in Silver Spring Maryland USA and ensuring consumer safety by reviewing $1 trillion+ consumer healthcare products https://www.fda.gov
o. 4-30-19: Arrayit sales and marketing team reports $190,400 contractor sourcing request from the prestigious United States Food and Drug Administration FDA HQ in Silver Spring Maryland USA and regulating clinical products totaling $1 trillion in annual revenues https://www.fda.gov
p. 5-17-19:Arrayit sales and marketing team quotes $495,140 microarray life sciences services sale to the prestigious United States Food and Drug Administration FDA headquartered in Silver Spring Maryland USA and ensuring the safety of $1 trillion consumer products https://www.fda.gov
q. 5-21-19: Arrayit clinical sales team quotes $228,580 clinical testing services sale to the prestigious United States Food and Drug Administration FDA headquartered Silver Spring Maryland USA and regulating medical products with annual revenues topping $1 trillion https://www.fda.gov
r. 5-23-19: Arrayit clinical sales team quotes $3,808,000 clinical testing services sale to the world renowned United States Food and Drug Administration FDA HQ in Silver Spring Maryland USA and ensuring consumer product safety topping $1 trillion in annual revenues http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
Good morning ARYC!
For those new to Arrayit it would be wise to take the time to read through Stock Detective's post history for excellent DD on everything this 25 year old Silicon Valley company is working on, plus the government agencies they are currently working with or selling to. He posts links to verify, not merely his opinions. I believe we have an amazing opportunity in front of us, just a matter of doing some DD.
$ARYC
I agree-I believe when more information comes out on our COVID-19 test we can expect similar price action.
That's all true- the trading the last few days has been very solid!
Agree cj - any buys near our current level will be looking very well in the coming days and weeks.
Major company updates coming soon I believe as well! Holding for multi dollars:)
Trying to buy those shares back you sold.
Yes sir, sustained run in the making due to massive catalysts in the works. COVID-19 test is only icing on the cake.
This is a highly undervalued Silicon Valley biotech company.
http://www.arrayit.com/
CLIA Laboratory Demographic Information Report: CLIA Number: 05D2147467
https://www.cms.gov/apps/clia/clia_start.asp?CLIANum=05D2147467&LabName=&GeoCity=&state=AK&GeoZip=&appType=%25&isSubmitted=clia2
http://arrayit.com/Clinical/CLIA_Laboratory/clia_laboratory.html
Fingerstick Allergy Program Overview
Reposting this excellent post by Stock Detective. Great information for those new on Arrayit's business:
My friend. Arrayit has a major product line pending FDA approval... Many here, including myself, believe that this product line may be the ovarian cancer test. I believe the ovarian cancer test requires the use of the Arrayit Blood Card described on the link below, therefore, the company probably submitted both at the same time.
http://shop.arrayit.com/blood_card.aspx
http://shop.arrayit.com/OvaDx.aspx
I believe the Arrayit Blood Card is also utilized for the Parkinson’s Disease testing described on the links below.
http://shop.arrayit.com/Parkinsons_Disease.aspx
http://www.lobov.com.ar/parkinsons-disease/
Now, I have never seen the term “Arrayit Blood Card” used in any other clinical trial in the past. Maybe MikeCr or Delsurfer who have been here longer can either confirm or disprove that. On the link below it describes that Arrayit Blood Cards being used in a recent clinical trial.
https://www.clinicaltrials.gov/ct2/show/record/NCT04095052?view=record
Further, Arrayit also has confidential contracts with the FDA and shipped the instrumentation and software to them back in 2018.
https://finance.yahoo.com/news/arrayit-corporation-fulfills-clinical-instrumentation-103000472.html
https://www.fpds.gov/ezsearch/fpdsportal?q=arrayit&s=FPDSNG.COM&templateN=&&templateName=1.5.1&indexName=awardfull
For the allergy fingerstick test (IgE), Arrayit requires 4 drops of blood on the on the product described down below (this product is different from the Arrayit Blood Card described up top for in vitro diagnostic testing, requiring 5 drops of blood).
http://shop.arrayit.com/blood-card-punch.aspx
For the food intolerance fingerstick test (IgG), Arrayit requires 1 drop as IgG is more abundant in the human bloodstream.
https://pinnertest.com/
“In case you hadn't heard, Arrayit is now a Medicare in-network provider. Offering one-of-a-kind Allergy Testing that's fast, convenient and most importantly, billable. Review the data that supports this success, and leverage this success for your own clinic.”
https://www.patientdatasolutions.com/medicare.jsp
Centers for Medicare & Medicaid Services:
https://www.cms.gov/apps/clia/clia_start.asp?CLIANum=05D2147467&LabName=&GeoCity=&state=AK&GeoZip=&appType=%25&isSubmitted=clia2
https://npiregistry.cms.hhs.gov/registry/provider-view/1104316157
Arrayit Corporation Approved as New Medicare Part B Healthcare Provider for Allergy Testing Services
https://www.globenewswire.com/news-release/2019/08/12/1900293/0/en/Arrayit-Corporation-Approved-as-New-Medicare-Part-B-Healthcare-Provider-for-Allergy-Testing-Services.html
repost:
On May 7, 2019, at 11:52 PM, ___wrote:
Hi Mark,
Hope all is well.
Any info on finger stick tests being used in other Markets than Allergy, asthma and intolerance?
"We plan to use the finger stick collection method for all of our pipeline tests including ovarian cancer, Parkinson’s Disease and others. In principle, this sampling method can be used to test for all 7,700 known human conditions."
We do know that iconic holdings lost the case and that settlement is soon. I believe they sold shares - hopefully we find out very soon.
Yes sir .05 coming soon- let's get it done Arrayit!
Iconic needs to hit the ask:)
For those new to Arrayit:
Arrayit recently completed an allergy testing pilot program for a top retail chain, established a nationwide network of 1,700 allergy sales professionals, met with top officials at the United States Food and Drug Administration (FDA) regarding approval of a major product line, fulfilled an FDA clinical instrumentation contract, received approval for in-store promotions by a major retailer, announced allergy testing partnerships with major allergy therapeutics providers, received approval for direct Medicare billing and electronic Medicare reimbursement from the Centers for Medicare and Medicaid Services, launched the Patient Data Solutions allergy portal for doctors and clinics, celebrated 25 years of company operations, announced an allergy testing services agreement with a major health and wellness provider, provided a letter to shareholders from the company's Chief Executive Officer, received endorsement by First Pediatrics Medical Group, announced in-network allergy testing services contracting with a top five commercial health benefits company, doubled its weekly billing guidance to $2 million per week, appointed an Apple enterprise healthcare partner to accelerate revenues and earnings growth, expanded allergy testing services evaluation with a major retail pharmacy chain, grew its allergy testing healthcare network to more than 700 clinics, retained a top credentialing company to accelerate commercial and government payor reimbursement, aced five consecutive rounds of proficiency testing with a top proficiency testing leader, signed an in-network allergy testing services agreement with a major California-based health benefits company, received a certificate of deemed status into 2020 from the California Department of Public Health and expanded its clinic network in Hawaii. Philippines test revenues and earnings will be reported in the company's upcoming audited quarterly and annual financial statements.
CEO Rene Schena states, "Global expansion of our health and wellness testing services in the Philippines is in keeping with our mission to make healthcare more accessible internationally. With universal healthcare coverage and a rising standard of living, the Philippines offers a tremendous growth opportunity for Arrayit and its shareholders as we expand into Southeast Asia and points beyond."
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads and empowers the biotechnology, pharmaceutical, clinical and healthcare sectors through the discovery, development and manufacture of proprietary life science and personalized medicine products and services to advance biomedical research and improve human health and wellness. Please visit www.arrayit.com for more information.
https://www.marketwatch.com/press-release/arrayit-corporation-announces-global-expansion-of-finger-stick-health-and-wellness-testing-services-2019-07-29-61841734?siteid=bigcharts&dist=bigcharts
Look at these tweets from august, we can handle the volume even before expansion plans go into effect:
8-8-19: Arrayit clinical team commences $240,000,000 test kit manufacturing run to build inventory for our rapidly expanding physician-ordered finger stick allergy testing services empowering clinic network doctors to identify, manage and treat allergy and asthma http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
Arrayit clinical team commences $240,000,000 test kit manufacturing run to build inventory for our rapidly expanding physician-ordered finger stick allergy testing services empowering clinic network doctors to identify, manage and treat allergy and asthma https://t.co/To67BQtJJq pic.twitter.com/N4Sy6NFZgJ
— Arrayit Corporation (@arrayit) August 8, 2019
That's true- wish we knew how many shares iconic holdings is purchasing. Million share bid as expected looking sweet:)
Now we got a big bid - iconic purchasing more?
Thanks for posting cary!
Yes sir, COVID-19 test is one of many catalysts in the pipeline.
I agree - It's the real deal.
Not much for sale at .03, could blow right past it, and should with the news we got last night.
That's true - .03's coming very soon.
Sounds like a wise move, wish I could say the same.
That's the truth, but it's coming:) Many exciting developments.
Nice bid rokk- you could sell all your shares today if you don't like the company?
One of many exciting developments for Arrayit!
Huge News!!! www.arrayit.com/SARS-CoV-2COVID-19TestInstructions.pdf
$$ ARYC $$
Good deal - lock them up for dollars!
Nice L2 - Solid buys coming in this morning.
Thanks for keeping us updated with the latest Arrayit developments!
Silicon Valley biotech company Arrayit Corporation [OTC: ARYC] CoronaVirus (COVID-19) test confirmation after hours yesterday:
www.arrayit.com/SARS-CoV-2COVID-19TestInstructions.pdf
http://www.arrayit.com/
If you live in or near the bay area you can stop by to visit the company. They are very shareholder friendly.
Arrayit Corporation
927 Thompson Place
Sunnyvale, CA 94085
USA
Phone 408-744-1331
FAX 408-744-1711
Email arrayit@arrayit.com
Web www.arrayit.com
http://www.arrayit.com/
https://www.facebook.com/Arrayit/
http://twitter.com/arrayit
Global DNA Microarray Market top players : Arrayit
https://www.marketwatch.com/press-release/dna-and-gene-chip-market-overview-growth-factors-and-competitive-players-till-2027-2019-01-31?siteid=bigcharts&dist=bigcharts
CLIA Laboratory Demographic Information Report: CLIA Number: 05D2147467
https://www.cms.gov/apps/clia/clia_start.asp?CLIANum=05D2147467&LabName=&GeoCity=&state=AK&GeoZip=&appType=%25&isSubmitted=clia2
http://arrayit.com/Clinical/CLIA_Laboratory/clia_laboratory.html
Fingerstick Allergy Program Overview
https://www.twinarborlabs.com/
Third paragraph on the twin arbor touting Arrayit crada technology in use. More revenue streams!
Cutting Edge Technology
Twin Arbor Analytical utilizes cutting edge technologies such as Arrayit’s (ARYC) proprietary microarray platform. This system was developed as a research cooperative agreement with the United States Department of Agriculture – Agricultural Research Services (USDA-ARS) as a low-cost high throughput system for the analysis of microbial contaminants such as E. coli, salmonella, listeria, Noro virus and Hepatitis A.
https://www.ars.usda.gov/research/project/?accnNo=430420
https://www.ars.usda.gov/research/publications/publication/?seqNo115=342006
repost: The science behind how Arrayit tests for COVID-19 among others - thanks for sharing.
Sensors (Basel). 2017 Sep; 17(9): 2157.
Published online 2017 Sep 20. doi: 10.3390/s17092157
PMCID: PMC5621023
PMID: 28930175
Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform
Beatriz Quiñones,1,* Bertram G. Lee,1 Todd J. Martinsky,2 Jaszemyn C. Yambao,1 Paul K. Haje,2 and Mark Schena2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621023/